Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,378
Total Claims
$965K
Drug Cost
458
Beneficiaries
$2,107
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-79%
Opioid rate vs peers
0.5% vs 2.5% avg
+87%
Cost per patient vs peers
$2,107 vs $1,128 avg
+52%
Brand preference vs peers
12.8% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.5%
Opioid Rate
73
Opioid Claims
$359
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,817 claims · $799K
Generic: 12,381 claims · $162K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phos/Metformin Hcl | 141 | $124K |
| Insulin Glargine,hum.Rec.Anlog | 165 | $77K |
| Apixaban | 77 | $54K |
| Rivaroxaban | 40 | $38K |
| Insulin Lispro | 48 | $30K |
| Dulaglutide | 31 | $29K |
| Dapagliflozin Propanediol | 40 | $26K |
| Insulin Nph Human Isophane | 64 | $25K |
| Budesonide/Formoterol Fumarate | 63 | $24K |
| Levothyroxine Sodium | 274 | $23K |
| Insulin Nph Hum/Reg Insulin Hm | 54 | $22K |
| Empagliflozin | 24 | $20K |
| Tiotropium Bromide | 32 | $17K |
| Insulin Glargine/Lixisenatide | 19 | $16K |
| Empaglifloz/Linaglip/Metformin | 14 | $14K |
Prescribing Profile
Patient Profile
72
Avg Age
55%
Female
2.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data